맞춤형 의료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global personalised medicine market size is expected to reach USD 1390.02 Billion in 2034 from USD 641.59 Billion in 2025, growing at a CAGR of 8.97 during 2026-2034.This market is witnessing remarkable growth as healthcare systems increasingly shift from standardized treatment approaches toward individualized therapies based on genetic, molecular, and clinical characteristics. Growing prevalence of chronic diseases, expanding genomic research, and advancements in molecular diagnostics are encouraging widespread adoption of personalized medicine. Healthcare providers are utilizing patient-specific data to improve treatment accuracy, minimize adverse effects, and enhance overall clinical outcomes across multiple therapeutic areas.

Rapid progress in genomics, artificial intelligence, bioinformatics, biomarker discovery, and companion diagnostics is driving significant industry development. Pharmaceutical companies are investing heavily in precision therapeutics, targeted drug development, and advanced diagnostic platforms that enable customized treatment strategies. Expanding availability of genomic sequencing services, favorable regulatory initiatives, and increasing collaboration between biotechnology firms and healthcare institutions are further accelerating commercialization worldwide.

Future growth prospects remain highly favorable as gene editing, cell therapies, pharmacogenomics, and digital health technologies continue advancing. Artificial intelligence-assisted clinical decision-making, predictive analytics, and real-time patient monitoring will further strengthen personalized healthcare delivery. Increasing healthcare investments, broader access to genetic testing, and continuous scientific breakthroughs will continue supporting sustained long-term expansion throughout the personalized medicine industry.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Personalized Medicine Diagnostics (Genetic Testing, Direct-To-Consumer (DTC) Diagnostics, Esoteric Lab Services, Esoteric Lab Tests)
• Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices)
• Personalized Medical Care (Telemedicine, Health Information Technology)
• Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine)

By End Use

• Hospitals
• Diagnostic Centers
• Research & Academic Institutes
• Others

COMPANIES PROFILED

• Abbott, Asuragen Inc., Biogen Inc., Celera Diagnostics LLC, Dako A/S, Danaher Corporation, deCODE genetics Inc., Exact Sciences Corporation, Exagen Inc., GE HealthCare Technologies Inc., Genentech Inc., Genelex Corporation, Illumina Inc., International Business Machines Corporation (IBM), Precision Biologics Inc., QIAGEN N.V.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERSONALISED MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Personalized Medicine Diagnostics (Genetic Testing, Direct-To-Consumer (DTC) Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Personalized Medical Care (Telemedicine, Health Information Technology) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERSONALISED MEDICINE MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERSONALISED MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PERSONALISED MEDICINE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott
  • 8.2.2 Asuragen Inc
  • 8.2.3 Biogen Inc
  • 8.2.4 Celera Diagnostics LLC
  • 8.2.5 Dako A/S
  • 8.2.6 Danaher Corporation
  • 8.2.7 DeCODE Genetics Inc
  • 8.2.8 Exact Sciences Corporation
  • 8.2.9 Exagen Inc
  • 8.2.10 GE HealthCare Technologies Inc
  • 8.2.11 Genentech Inc
  • 8.2.12 Genelex Corporation
  • 8.2.13 Illumina Inc
  • 8.2.14 International Business Machines Corporation (IBM)
  • 8.2.15 Precision Biologics Inc
  • 8.2.16 QIAGEN N.V